Literature DB >> 28536891

Myocardial voltage ratio in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Andreas Müssigbrodt1, Livio Bertagnolli2, Elena Efimova2, Jedrzej Kosiuk2, Borislav Dinov2, Kerstin Bode2, Simon Kircher2, Nikolaos Dagres2, Michael Döring2, Sergio Richter2, Philipp Sommer2, Daniela Husser2, Andreas Bollmann2, Gerhard Hindricks2, Arash Arya2.   

Abstract

AIMS: This study aimed to analyze the influence of scar distribution between the endocardium and the epicardium in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C).
METHODS: Electroanatomical mapping data were derived from our ARVD/C registry. Myocardial voltage distribution between the endocardium and the epicardium was analyzed in 28 patients (18 men, 49.9 ± 13.0 years) with previous ventricular tachycardia (VT) ablation and complete right ventricular maps.
RESULTS: During the follow-up period of 28 ± 22 months after ablation, 18 of 28 patients (64.3%) remained free from VT recurrence. In univariate analysis, five variables associated with VT recurrence, i. e., advanced age, right ventricular (RV) myocardial voltage ratio ≥0.58, inducibility of VT after ablation, and longer procedure and fluoroscopy time. In binary logistic regression analysis only RV myocardial voltage ratio ≥0.58 (hazard ratio 11.667, 95% confidence interval 1.487-91.543, p = 0.012) remained associated with an increased risk of VT recurrence.
CONCLUSION: The myocardial voltage ratio (bipolar low voltage area/unipolar low voltage area) as a potential surrogate parameter for scar distribution between the endocardium and the epicardium is significantly associated with the outcome after VT ablation in ARVD/C.

Entities:  

Keywords:  Ablation techniques; Endocardium; Epicardium; Unipolar; Ventricular tachycardia

Mesh:

Year:  2017        PMID: 28536891     DOI: 10.1007/s00399-017-0508-0

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  30 in total

1.  Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.

Authors:  Aditya Bhonsale; Cynthia A James; Crystal Tichnell; Brittney Murray; Dmitri Gagarin; Binu Philips; Darshan Dalal; Ryan Tedford; Stuart D Russell; Theodore Abraham; Harikrishna Tandri; Daniel P Judge; Hugh Calkins
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.

Authors:  Frank I Marcus; William J McKenna; Duane Sherrill; Cristina Basso; Barbara Bauce; David A Bluemke; Hugh Calkins; Domenico Corrado; Moniek G P J Cox; James P Daubert; Guy Fontaine; Kathleen Gear; Richard Hauer; Andrea Nava; Michael H Picard; Nikos Protonotarios; Jeffrey E Saffitz; Danita M Yoerger Sanborn; Jonathan S Steinberg; Harikrishna Tandri; Gaetano Thiene; Jeffrey A Towbin; Adalena Tsatsopoulou; Thomas Wichter; Wojciech Zareba
Journal:  Eur Heart J       Date:  2010-02-19       Impact factor: 29.983

3.  Electroanatomic Correlates of Depolarization Abnormalities in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Authors:  Tanyanan Tanawuttiwat; Anneline S J M Te Riele; Binu Philips; Cynthia A James; Brittney Murray; Crystal Tichnell; Abhishek C Sawant; Hugh Calkins; Harikrishna Tandri
Journal:  J Cardiovasc Electrophysiol       Date:  2016-02-25

4.  Procedural Outcomes and Survival After Catheter Ablation of Ventricular Tachycardia in Relation to Electroanatomical Substrate in Patients With Nonischemic-Dilated Cardiomyopathy: The Role of Unipolar Voltage Mapping.

Authors:  Borislav Dinov; Alexandra Schratter; Valentina Schirripa; Lukas Fiedler; Andreas Bollmann; Sascha Rolf; Philipp Sommer; Gerhard Hindricks; Arash Arya
Journal:  J Cardiovasc Electrophysiol       Date:  2015-07-28

5.  Combined analysis of unipolar and bipolar voltage mapping identifies recurrences after unmappable scar-related ventricular tachycardia ablation.

Authors:  Kivanc Yalin; Ebru Golcuk; Ahmet Kaya Bilge; Tolga Aksu; Hakan Buyukbayrak; Selma Kenar Tiryakioglu; Samim Emet; Kamil Adalet
Journal:  Europace       Date:  2015-03-06       Impact factor: 5.214

6.  Electroanatomic mapping characteristics of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Hielko Miljoen; Simona State; Christian de Chillou; Isabelle Magnin-Poull; Pierre Dotto; Marius Andronache; Ahmed Abdelaal; Etienne Aliot
Journal:  Europace       Date:  2005-09-22       Impact factor: 5.214

7.  Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry.

Authors:  Zouheir Souissi; Stéphane Boulé; Jean-Sylvain Hermida; Alexandre Doucy; Philippe Mabo; Dominique Pavin; Frédéric Anselme; Nathanaël Auquier; Sandro Ninni; Augustin Coisne; François Brigadeau; Valérie Deken-Delannoy; Didier Klug; Dominique Lacroix
Journal:  Europace       Date:  2018-02-01       Impact factor: 5.214

8.  Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Glenn M Polin; Haris Haqqani; Wendy Tzou; Mathew D Hutchinson; Fermin C Garcia; David J Callans; Erica S Zado; Francis E Marchlinski
Journal:  Heart Rhythm       Date:  2010-11-27       Impact factor: 6.343

9.  Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Pasquale Santangeli; Erica S Zado; Gregory E Supple; Haris M Haqqani; Fermin C Garcia; Cory M Tschabrunn; David J Callans; David Lin; Sanjay Dixit; Mathew D Hutchinson; Michael P Riley; Francis E Marchlinski
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-11-06

10.  Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation.

Authors:  Senthil Kirubakaran; Caterina Bisceglia; John Silberbauer; Teresa Oloriz; Giulia Santagostino; Miki Yamase; Giuseppe Maccabelli; Nicola Trevisi; Paolo Della Bella
Journal:  Europace       Date:  2017-06-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.